Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05275530 · ClinicalTrials.gov registry record · NA
The Impact of Choice on Colorectal Cancer Screening
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 20,509
- Enrollment target
NCT05275530 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 20,509 participants.
The verdict
NCT05275530, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 20,509 participants
- Enrollment target
Study Summary
In May of 2021, the United States Preventive Service Task Force (USPSTF) updated their colorectal cancer (CRC) screening guidelines by recommending screening at an earlier age for average-risk adults starting at the age of 45 years old (Grade B recommendation). This is in addition to their Grade A recommendations of continuing to screen average-risk adults ages 50-75 years old. UCLA Health previously implemented a fecal immunochemical test (FIT) outreach program wherein FIT kits are mailed to average-risk patients overdue for CRC screening twice annually to promote screening uptake. As the investigators health system aims to screen the newly eligible population of average-risk patients between the ages of 45-49, the investigators proposed randomized controlled trial is aimed to determine the most effective patient outreach approach to maximize screening uptake within this age-group.
Interventions
- BEHAVIORAL Active FIT Choice
- BEHAVIORAL Active Colonoscopy Choice
- BEHAVIORAL Active Dual Choice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,509 participants |
| Start Date | 2022-02-21 |
| Est. Completion | 2022-11-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05275530
The ClinicalTrials.gov registry entry for NCT05275530 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20,509 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Active FIT Choice is the first listed.
NCT05275530 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05275530 about?
NCT05275530 is a clinical study titled "The Impact of Choice on Colorectal Cancer Screening". In May of 2021, the United States Preventive Service Task Force (USPSTF) updated their colorectal cancer (CRC) screening guidelines by recommending screening at an earlier age for average-risk adults starting at the age of 45 years old (Grade B recommendation). This is in addition to their Grade A r...
What is the current status of trial NCT05275530?
This trial is currently completed. It is a NA study. The enrollment target is 20,509 participants. The study started on 2022-02-21. Estimated completion is 2022-11-21.
What interventions are being tested in trial NCT05275530?
The interventions under investigation include: Active FIT Choice (BEHAVIORAL), Active Colonoscopy Choice (BEHAVIORAL), Active Dual Choice (BEHAVIORAL).
Who is sponsoring clinical trial NCT05275530?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.